77
36
Growth Score
-13 pts
Heat Score
-56 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
264805
Vivtex is a biotechnology company pioneering GI organ robotic interface technologies with AI to create new oral drugs
Jim Wright: SVP of Drug DevelopmentPast Role: BIND Therapeutics, CSO- Thomas von Erlach: Co-Founder and Chief Scientific Officer
About the Company
Vivtex is a biotechnology company pioneering new delivery technologies to enable new orally administered medicines. The company was co-founded by Drs. Robert S. Langer, Giovanni Traverso, and Thomas von Erlach. Vivtex’s platform integrates high-throughput screening, proprietary formulation libraries, and molecular modeling and AI-driven approaches
to support the development of oral biologic therapies. The company has research and development collaborations with leading biotechnology and pharmaceutical partners, with multiple oral peptide programs spanning preclinical through clinical stages. Vivtex’s vision is to empower patients with more convenient options for how they take their medicines.
